Last Updated on September 7, 2024 by The Health Master
Eye Drops
In a significant breakthrough for eye care, Entod Pharmaceuticals has secured approval from the Drug Controller General of India (DCGI) to market its innovative eye drops, PresVu.
This age-related vision condition, characterized by difficulty in focusing on close objects, affects millions worldwide.
PresVu: A Game-Changer for Presbyopia
The approval follows a positive recommendation from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO).
A Global Impact
With an estimated 1.09-1.8 billion people globally affected by presbyopia.
Entod Pharmaceuticals is poised to capitalize on this growing market, both domestically and internationally.
Expanding Horizons: Entod’s Future Plans
Entod Pharmaceuticals has ambitious plans to expand its reach beyond India.
The company is focusing on emerging markets like Africa and Southeast Asia, where access to quality healthcare is often limited.
Additionally, Entod aims to innovate products in India and license them to the US market, a region dominated by low-cost generics.
Addressing Unmet Healthcare Needs
Entod’s commitment to providing affordable and accessible medicines extends to regions like Africa, where many people lack access to essential healthcare.
By introducing new molecules that have not been offered by major pharmaceutical companies, Entod is working to address critical healthcare challenges.
Beyond Eye Care: Diversifying into Mental Health
While Entod Pharmaceuticals is currently focused on three therapeutic areas – ENT, ophthalmology, and dermatology – the company is exploring opportunities to enter the mental health segment.
Recognizing the growing need for mental healthcare services in India, Entod sees potential in this area.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Disclaimer: This content, including advice, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
Streamlining Indian Pharmaceutical Regulatory System: DCGI
DCGI announces Stringent Measures and Digital Transformation Plans
DCGI approval granted for this new Antibiotic Drug Combination
DCGI to SLAs: Cancel this Antibiotic Drug Combination
DCGI to Collaborate with Stakeholders: Empowering Ease of Doing Business
Pakistan: Drug Production Quality Under Scrutiny, Concerns Raised in Senate Committee
NDPS: Illegal Drug Manufacturing Unit busted in East Godavari
USFDA issues EIR for Marksans Pharma Goa facility
Indian Pharma Industry: A Global Powerhouse
USFDA approval granted for generic drug for Scalp Psoriasis Treatment
Huge stock of medicines seized: DCA Telangana
FSSAI: Food Labelling and Display – Chapter-9
USFDA issues warning letter to Zydus for injectables unit at Jarod
Streamlining Indian Pharmaceutical Regulatory System: DCGI
Strengthening Drug Regulatory System in India: A Comprehensive Analysis
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
